留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基于TCGA数据库分析POSTN在头颈部鳞癌中的表达和临床意义

张曼 周兰柱 孙哲 吴俊 王文忠

张曼, 周兰柱, 孙哲, 吴俊, 王文忠. 基于TCGA数据库分析POSTN在头颈部鳞癌中的表达和临床意义[J]. 中华全科医学, 2022, 20(6): 1066-1070. doi: 10.16766/j.cnki.issn.1674-4152.002525
引用本文: 张曼, 周兰柱, 孙哲, 吴俊, 王文忠. 基于TCGA数据库分析POSTN在头颈部鳞癌中的表达和临床意义[J]. 中华全科医学, 2022, 20(6): 1066-1070. doi: 10.16766/j.cnki.issn.1674-4152.002525
ZHANG Man, ZHOU Lan-zhu, SUN Zhe, WU Jun, WANG Wen-zhong. Analysis of the expression and clinical significance of POSTN in head and neck squamous carcinoma based on TCGA database[J]. Chinese Journal of General Practice, 2022, 20(6): 1066-1070. doi: 10.16766/j.cnki.issn.1674-4152.002525
Citation: ZHANG Man, ZHOU Lan-zhu, SUN Zhe, WU Jun, WANG Wen-zhong. Analysis of the expression and clinical significance of POSTN in head and neck squamous carcinoma based on TCGA database[J]. Chinese Journal of General Practice, 2022, 20(6): 1066-1070. doi: 10.16766/j.cnki.issn.1674-4152.002525

基于TCGA数据库分析POSTN在头颈部鳞癌中的表达和临床意义

doi: 10.16766/j.cnki.issn.1674-4152.002525
基金项目: 

安徽省高校自然科学研究项目 KJ2020A0568

详细信息
    通讯作者:

    王文忠, E-mail: 13955259093@163.com

  • 中图分类号: R739.91 R730

Analysis of the expression and clinical significance of POSTN in head and neck squamous carcinoma based on TCGA database

  • 摘要:   目的  利用在线数据库和生物信息学方法分析POSTN基因在头颈部鳞状细胞癌中的差异表达对其预后的临床意义,寻找头颈部鳞状细胞癌新的生物标志物。  方法  使用TCGA公共数据库获取头颈部鳞癌患者的基本信息、POSTN的表达情况;利用Kaplan-Meier Plotter分析不同POSTN表达水平的头颈部鳞癌患者生存曲线;采用TIMER数据库分析POSTN与头颈部鳞癌中各种免疫细胞浸润的相关性;GEPIA数据库分析POSTN表达与免疫细胞标志物表达的相关性;GO和KEGG基因富集分析探索POSTN共表达基因的功能及其作用通路。  结果  POSTN在头颈部鳞癌中高表达(P<0.05),其表达与头颈部鳞癌患者的预后呈正相关;头颈部鳞癌患者的累积生存率与多种免疫细胞的浸润程度相关;POSTN表达水平与头颈部鳞癌中的巨噬细胞浸润程度呈正相关关系(P=0.024),并与M2型巨噬细胞标志物呈正相关关系(P<0.001),POSTN高表达促进巨噬细胞向M2型极化。富集分析显示POSTN与细胞外基质调节过程相关。  结论  POSTN表达与头颈部鳞癌患者预后及免疫浸润相关,并且其可能通过调节巨噬细胞极化而导致患者的不良预后。

     

  • 图  1  POSTN在多种癌症中的表达差异

    注:ACC为肾上腺皮质癌;BLCA为膀胱尿路上皮癌;BRCA为乳腺浸润癌;BRCA为乳腺浸润癌;CESC为宫颈鳞癌和腺癌;CHOL为胆管癌;COAD为结肠癌;COAD为结肠癌;DLBC为弥漫性大B细胞淋巴瘤;ESCA为食管癌;GBM为多形成性胶质细胞瘤;HNSC为头颈鳞状细胞癌;KICH为肾嫌色细胞癌;KIRC为肾透明细胞癌;KIRP为肾乳头状细胞癌;LAML为急性髓细胞样白血病;LGG为脑低级别胶质瘤;LIHC为肝细胞肝癌;LUAD为肺腺癌;LUSC为肺鳞癌;MESO为间皮瘤;OV为卵巢浆液性囊腺癌;PAAD为胰腺癌;PCPG为嗜铬细胞瘤和副神经节瘤;PRAD为前列腺癌;READ为直肠腺癌;SARC为肉瘤;SKCM为皮肤黑色素瘤;STAD为胃癌;TGCT为睾丸癌;THCA为甲状腺癌;THYM为胸腺癌;UCEC为子宫内膜癌;UCS为子宫肉瘤;UVM为葡萄膜黑色素瘤。aP<0.01,bP<0.05。

    Figure  1.  Expression differences of POSTN in various cancers

    图  2  POSTN在头颈部鳞癌中的表达差异

    注:aP<0.05。红色为头颈部鳞癌组织,灰色为癌旁正常组织。

    Figure  2.  Expression differences of POSTN in head and neck squamous cell carcinoma

    图  3  POSTN对预后的影响

    Figure  3.  Effect of POSTN on prognosis

    表  1  头颈部鳞癌中POSTN表达水平与GEPIA数据库中免疫细胞标志物表达水平的相关性

    Table  1.   Correlation between the expression level of POSTN in head and neck squamous cell carcinoma and the expression level of immune cell markers in GEPIA database

    细胞种类 基因标志物 肿瘤 非肿瘤
    r P r P
    单核细胞 CD86 0.280 < 0.001 0.190 0.220
    CD115(CSF1R) 0.140 < 0.001 0.280 0.062
    肿瘤相关巨噬细胞 CCL2 0.290 < 0.001 0.200 0.190
    CD68 0.330 < 0.001 0.055 0.730
    IL-10 0.370 < 0.001 0.160 0.300
    M1型巨噬细胞 INOS(NOS2) -0.069 0.120 -0.110 0.470
    IRF5 0.010 0.820 -0.200 0.200
    COX2(PTGS2) -0.041 0.350 0.032 0.320
    M2型巨噬细胞 CD163 0.350 < 0.001 0.680 < 0.001
    MS4A4A 0.370 < 0.001 0.420 0.005
    下载: 导出CSV

    表  2  POSTN的GO功能富集和KEGG通路富集分析

    Table  2.   GO functional enrichment and KEGG pathway enrichment analysis of POSTN

    类别 名称 P 数量
    BP 细胞外结构组织 <0.001 55
    BP 细胞外基质组织 <0.001 52
    BP 骨化作用 <0.001 35
    BP 胶原蛋白纤维组织 <0.001 16
    BP 肌肉系统形成 <0.001 31
    CC 含胶原蛋白的细胞外基质 <0.001 62
    CC 胶原蛋白三聚体 <0.001 20
    CC 内质网腔体 <0.001 26
    CC 纤维状胶原蛋白三聚体 <0.001 7
    CC 带状胶原蛋白纤维 <0.001 7
    MF 细胞外基质结构成分 <0.001 39
    MF 胶原蛋白结合 <0.001 16
    MF 整合素结合 <0.001 20
    MF 赋予抗拉强度的细胞外基质结构成分 <0.001 13
    MF 糖胺聚糖结合 <0.001 24
    KEGG ECM-受体的相互作用 <0.001 16
    KEGG PI3K-Akt信号通路 <0.001 23
    KEGG 蛋白质消化吸收 <0.001 13
    KEGG 局部黏附 <0.001 16
    KEGG 人乳头瘤病毒感染 <0.001 18
    注:BP为生物过程,MF为分子功能,CC为细胞定位。
    下载: 导出CSV
  • [1] Global Burden of Disease Cancer Collaboration, FITZMAURICE C, ABATE D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2019, 5(12): 1749-1768. doi: 10.1001/jamaoncol.2019.2996
    [2] 蒋华丽, 杨成, 翁芬女, 等. 头颈部肿瘤放疗患者自我感受负担现状及影响因素分析[J]. 中华全科医学, 2019, 17(1): 144-146, 153. doi: 10.16766/j.cnki.issn.1674-4152.000623

    JIANG H L, YANG C, WENG F N, et al. Study on the status of self-perceived burden and its influencing factors in patients with head and neck tumor for radiotherapy[J]. Chinese Journal of General Practice, 2019, 17(1): 144-146, 153. doi: 10.16766/j.cnki.issn.1674-4152.000623
    [3] 罗俊婷, 胡欣, 陈国芳, 等. 骨膜蛋白与代谢性疾病[J]. 国际内分泌代谢杂志, 2018, 38(1): 26-28. doi: 10.3760/cma.j.issn.1673-4157.2018.01.007

    LUO J T, HU X, CHEN G F, et al. Periostin and metabolic diseases[J]. International JOurnal of Endocrinology and Metabolism, 2018, 38(1): 26-28. doi: 10.3760/cma.j.issn.1673-4157.2018.01.007
    [4] OH H J, BAE J M, WEN X Y, et al. Overexpression of POSTN in tumor stroma is a poor prognostic indicator of colorectal cancer[J]. J Pathol Transl Med, 2017, 51(3): 306-313. doi: 10.4132/jptm.2017.01.19
    [5] 冀慎英, 张湘豫, 邹先琼. S100A8/A9在头颈部肿瘤发生发展中的作用及机制[J]. 医学综述, 2020, 26(21): 4235-4240. doi: 10.3969/j.issn.1006-2084.2020.21.015

    JI S Y, ZHANG X Y, ZOU X Q. Roles and mechanisms of S100A8/A9 in initiation and progression of head and neck cancer[J]. Medical Recapitulate, 2020, 26(21): 4235-4240. doi: 10.3969/j.issn.1006-2084.2020.21.015
    [6] ROUTRAY S, KUMAR R, DATTA K K, et al. An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma[J]. Sci Rep, 2021, 11(1): 6208. doi: 10.1038/s41598-021-85729-x
    [7] WANG Z C, CHEN M L, QIU Y B, et al. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment[J]. Biosci Rep, 2021, 41(2): BSR20202 439. doi: 10.1042/BSR20202439
    [8] RATAJCZAK-WIELGOMAS K, KMIECIK A, GRZEGRZOŁKA J, et al. Prognostic significance of stromal periostin expression in non-small cell lung cancer[J]. Int J Mol Sci, 2020, 21(19): 7025. doi: 10.3390/ijms21197025
    [9] CHEN K, LI Z H, ZHANG M Y, et al. MiR-876 inhibits EMT and liver fibrosis via POSTN to suppress metastasis in hepatocellular carcinoma[J]. BioMed Res Int, 2020. DOI: 10.1155/2020/1964219.
    [10] 郭小凡. 低氧促进胶质母细胞瘤抑制性免疫微环境的形成[D]. 济南: 山东大学, 2020.

    GUO X F. Hypoxia promotes the formation of inhibitory immune microenvironment in glioblastoma[D]. Jinan: Shandong University, 2020.
    [11] ZHU M H, ZHANG C Y, CHEN D H, et al. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma[J]. Biomed Pharmacother, 2019. DOI: 10.1016/j.biopha.2019.108998.
    [12] OKAZAKI T, TAMAI K, SHIBUYA R, et al. Periostin is a negative prognostic factor and promotes cancer cell proliferation in non-small cell lung cancer[J]. Oncotarget, 2018, 9(58): 31187-31199. doi: 10.18632/oncotarget.25435
    [13] CHEN G, WANG Y, ZHAO X, et al. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation[J]. J Exp Clin Cancer Res, 2021, 40(1): 218. doi: 10.1186/s13046-021-02011-8
    [14] TANG M, LIU B J, BU X C, et al. Cross-talk between ovarian cancer cells and macrophages through periostin promotes macrophage recruitment[J]. Cancer Sci, 2018, 109(5): 1309-1318. doi: 10.1111/cas.13567
    [15] ARNETH B. Tumor microenvironment[J]. Medicina (Kaunas), 2019, 56(1): 15. doi: 10.3390/medicina56010015
    [16] LIN B, Li H, ZHANG T W, et, al. Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer[J]. Aging (Albany NY), 2021, 13(4): 5718-5747.
    [17] GAMBARDELLA V, CASTILLO J, TARAZONA N, et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target[J]. Cancer Treat Rev, 2020, 86: 102015. DOI: 10.1016/j.ctrv.2020.102015.
    [18] MA C Y, HORLAD H, OHNISHI K, et al. CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma[J]. Med Mol Morphol, 2018, 51(1): 13-20. doi: 10.1007/s00795-017-0165-8
    [19] MATTIOLA I, TOMAY F, DE P M, et al. The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis[J]. Nat Immunol, 2019, 20(8): 1012-1022. doi: 10.1038/s41590-019-0417-y
    [20] WALKER C, MOJARES E, DEL RÍO HERNÁNDEZ A. Role of extracellular matrix in development and cancer progression[J]. Int J Mol Sci, 2018, 19(10): 3028.
    [21] PETROSYAN A, DA S S, TRIPURANENI N, et al. A step towards clinical application of acellular matrix: A clue from macrophage polarization[J]. Matrix Biol, 2017, 57-58: 334-346. DOI: 10.1016/j.matbio.2016.08.009.
  • 加载中
图(3) / 表(2)
计量
  • 文章访问数:  244
  • HTML全文浏览量:  126
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-01-25
  • 网络出版日期:  2022-09-21

目录

    /

    返回文章
    返回